{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T01:02:18Z","timestamp":1773622938784,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,25]],"date-time":"2006-03-25T00:00:00Z","timestamp":1143244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,3,25]],"date-time":"2006-03-25T00:00:00Z","timestamp":1143244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s10067-006-0252-z","type":"journal-article","created":{"date-parts":[[2006,3,24]],"date-time":"2006-03-24T11:24:12Z","timestamp":1143199452000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["RETRACTED ARTICLE: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Jun","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,25]]},"reference":[{"key":"252_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1023\/A:1010054924085","volume":"2","author":"E Seeman","year":"2001","unstructured":"Seeman E (2001) Unresolved issues in osteoporosis in men. Rev Endocr Metab Disord 2:45\u201364","journal-title":"Rev Endocr Metab Disord"},{"key":"252_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/er.2001-9002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570\u2013578","journal-title":"Endocr Rev"},{"key":"252_CR3","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa030897","volume":"350","author":"HG Bone","year":"2004","unstructured":"Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA; Alendronate Phase III Osteoporosis Treatment Study Group (2004) Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189\u20131199","journal-title":"N Engl J Med"},{"key":"252_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1056\/NEJM200008313430902","volume":"343","author":"E Orwoll","year":"2000","unstructured":"Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604\u2013610","journal-title":"N Engl J Med"},{"key":"252_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s001980200013","volume":"13","author":"JD Ringe","year":"2002","unstructured":"Ringe JD, Orwoll E, Daifotis A, Lombardi A (2002) Treatment of male osteoporosis: recent advances with alendronate. Osteoporos Int 13:195\u2013199","journal-title":"Osteoporos Int"},{"key":"252_CR6","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M; The Alendronate Phase III Osteoporosis Treatment Study Group (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437\u20131443","journal-title":"N Engl J Med"},{"key":"252_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE; Fracture Intervention Trial Research Group (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"252_CR8","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077\u20132082","journal-title":"JAMA"},{"key":"252_CR9","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s007740050038","volume":"16","author":"H Orimo","year":"1998","unstructured":"Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, Oh-hashi Y (1998) Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 16:139\u2013150","journal-title":"J Bone Miner Metab"},{"key":"252_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331\u2013337","journal-title":"J Bone Miner Metab"},{"key":"252_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s001980050214","volume":"10","author":"M Shiraki","year":"1999","unstructured":"Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Taga M, Nakamura T, Kaneda K, Minaguchi H, Inoue H, Morii H, Tomita A, Yamamoto K, Nagata Y, Nakashima M, Orimo H (1999) A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. Osteoporos Int 10:183\u2013192","journal-title":"Osteoporos Int"},{"issue":"9","key":"252_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0011-393X(02)80065-0","volume":"63","author":"K Kushida","year":"2002","unstructured":"Kushida K, Shiraki M, Nakamura T, Kishimoto H, Morii H, Yamamoto K, Kaneda K, Fukunaga M, Inoue T, Nakashima M, Orimo H (2002) The efficacy of alendronate in reducing the risk for vertebral fracture in Japanese patients with osteoporosis: a randomized, double-blind, active-controlled, double-dummy trial. Curr Ther Res 63(9):606\u2013620","journal-title":"Curr Ther Res"},{"key":"252_CR13","first-page":"1693","volume":"79","author":"P Garnero","year":"1994","unstructured":"Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693\u20131700","journal-title":"J Clin Endocrinol Metab"},{"key":"252_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","volume":"13","author":"SL Greenspan","year":"1998","unstructured":"Greenspan SL, Parker RA, Ferguson L, Rosen NH, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13:1431\u20131438","journal-title":"J Bone Miner Res"},{"key":"252_CR15","first-page":"3109","volume":"85","author":"RP Tonino","year":"2000","unstructured":"Tonino RP, Meunier PJ, Emkey R, Rodriguez-Portales JA, Menkes CJ, Wasnich RD, Bone HG, Wu M, Desai R, Ross PD (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab 85:3109\u20133115","journal-title":"J Clin Endocrinol Metab"},{"key":"252_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00774-004-0590-3","volume":"23","author":"J Iwamoto","year":"2005","unstructured":"Iwamoto J, Takeda T, Sato Y, Uzawa M (2005) Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with one-year response of lumbar bone mineral density to alendronate in Japanese postmenopausal women with osteoporosis. J Bone Miner Metab 23:238\u2013242","journal-title":"J Bone Miner Metab"},{"key":"252_CR17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00774-004-0547-6","volume":"23","author":"Y Nishizawa","year":"2005","unstructured":"Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M; Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis Japan Osteoporosis Society (2005) Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). J Bone Miner Metab 23:97\u2013104","journal-title":"J Bone Miner Metab"},{"key":"252_CR18","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","volume":"15","author":"P Garnero","year":"2000","unstructured":"Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526\u20131536","journal-title":"J Bone Miner Res"},{"key":"252_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1365-2362.1992.tb01503.x","volume":"22","author":"H Resch","year":"1992","unstructured":"Resch H, Pietschmann P, Woloszczuk W, Krexner E, Bernecker P, Willvonseder R (1992) Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis. Eur J Clin Invest 22:542\u2013545","journal-title":"Eur J Clin Invest"},{"key":"252_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/8756-3282(94)90790-0","volume":"15","author":"CA Sharp","year":"1994","unstructured":"Sharp CA, Worsfold M, Rowlands PR, Davie MWJ (1994) Accurate prediction of spinal osteoporosis in men using a biochemical measure of collagen balance. Bone 15:243","journal-title":"Bone"},{"key":"252_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4065\/80.3.379","volume":"80","author":"S Epstein","year":"2005","unstructured":"Epstein S (2005) The role of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy. Mayo Clin Proc 80:379\u2013388","journal-title":"Mayo Clin Proc"},{"key":"252_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00223-002-1085-7","volume":"73","author":"S Gonnelli","year":"2003","unstructured":"Gonnelli S, Cepollaro C, Montagnani A, Bruni D, Caffarelli C, Breschi M, Gennari L, Gennari C, Nuti R (2003) Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 73:133\u2013139","journal-title":"Calcif Tissue Int"},{"key":"252_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/PL00004182","volume":"11","author":"YV Ho","year":"2000","unstructured":"Ho YV, Frauman AG, Thomson W, Seeman E (2000) Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 11:98\u2013101","journal-title":"Osteoporos Int"},{"key":"252_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1517\/14656566.6.1.45","volume":"6","author":"TH Diamond","year":"2005","unstructured":"Diamond TH (2005) Pharmacotherapy of osteoporosis in men. Expert Opin Pharmacother 6:45\u201358","journal-title":"Expert Opin Pharmacother"}],"updated-by":[{"DOI":"10.1007\/s10067-021-05788-3","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"record-id":"29812"},{"DOI":"10.1007\/s10067-021-05788-3","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-006-0252-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0252-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0252-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T08:37:20Z","timestamp":1626683840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-006-0252-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,25]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0252-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,25]]},"assertion":[{"value":"26 May 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-021-05788-3","URL":"https:\/\/doi.org\/10.1007\/s10067-021-05788-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}